The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review
Open accessAbstract
BACKGROUND: The amount a government should be willing to invest in adopting new medical treatments has long been under debate. With many countries using formal cost-effectiveness (C/E) thresholds when examining potential new treatments and ever-growing medical costs, accurately setting the level of a C/E threshold can be essential for an efficient healthcare system. OBJECTIVES: The aim of this systematic review is to describe the prominent approaches to setting a C/E threshold, compile available national-level C/E threshold data and willingness-to-pay (WTP) data, and to discern whether associations exist between these values, gross domestic product (GDP) and health-adjusted life expectancy (HALE). This review further examines current obstacles faced with the presently available data. METHODS: A systematic review was performed to collect articles which have studied national C/E thresholds and willingness-to-pay (WTP) per quality-adjusted life year (QALY) in the general population. Associations between GDP, HALE, WTP, and C/E thresholds were analyzed with correlations. RESULTS: Seventeen countries were identified from nine unique sources to have formal C/E thresholds within our inclusion criteria. Thirteen countries from nine sources were identified to have WTP per QALY data within our inclusion criteria. Two possible associations were identified: C/E thresholds with HALE (quadratic correlation of 0.63), and C/E thresholds with GDP per capita (polynomial correlation of 0.84). However, these results are based on few observations and therefore firm conclusions cannot be made. CONCLUSIONS: Most national C/E thresholds identified in our review fall within the WHO's recommended range of one-to-three times GDP per capita. However, the quality and quantity of data available regarding national average WTP per QALY, opportunity costs, and C/E thresholds is poor in comparison to the importance of adequate investment in healthcare. There exists an obvious risk that countries might either over- or underinvest in healthcare if they base their decision-making process on erroneous presumptions or non-evidence-based methodologies. The commonly referred to value of 100,000$ USD per QALY may potentially have some basis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold
Neumann, P. J., Cohen, J. T., & Weinstein, M. C. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1405158 · Cited by 2,249
The Links Between Education and Health
Ross, C. E., & Wu, C.-L. (1995) · American Sociological Review · doi:10.2307/2096319 · Cited by 1,943
Salomon, J. A., Wang, H., Freeman, M. K., Vos, T., Flaxman, A. D., Lopez, A. D., & Murray, C. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61690-0 · Cited by 1,116
Thresholds for the cost–effectiveness of interventions: alternative approaches
Marseille, E., Larson, B., Kazi, D. S., Kahn, J. G., & Rosen, S. (2015) · Bulletin of the World Health Organization · doi:10.2471/blt.14.138206 · Cited by 851
Eichler, H.-G., Kong, S. X., Gerth, W. C., Mavros, P., & Jönsson, B. (2004) · Value in Health · doi:10.1111/j.1524-4733.2004.75003.x · Cited by 788
Shiroiwa, T., Sung, Y., Fukuda, T., Lang, H., Bae, S., & Tsutani, K. (2010) · Health Economics · doi:10.1002/hec.1481 · Cited by 690
Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
Grosse, S. D. (2008) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.8.2.165 · Cited by 637
Murray, C. J., Lauer, J. A., Hutubessy, R. C., Niessen, L., Tomijima, N., Rodgers, A., Lawes, C. M., & Evans, D. B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12655-4 · Cited by 599
Whose Utilities for Decision Analysis?
Boyd, N. F., Sutherland, H. J., Heasman, K. Z., Tritchler, D. L., & Cummings, B. J. (1990) · Medical Decision Making · doi:10.1177/0272989x9001000109 · Cited by 381
Problems and solutions in calculating quality-adjusted life years (QALYs).
Prieto, L. M., & Sacristán, J. A. (2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-80 · Cited by 363
Cited by
Ziegelmayer, S., Graf, M., Makowski, M., Gawlitza, J., & Gassert, F. (2022) · Cancers · doi:10.3390/cancers14071729 · Cited by 63
Cost-effectiveness of Artificial Intelligence–Based Retinopathy of Prematurity Screening
Morrison, S. L., Dukhovny, D., Chan, R. V. P., Chiang, M. F., & Campbell, J. P. (2022) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2022.0223 · Cited by 61
Metadata
- Authors
- Cameron, D., Ubels, J., & Norström, F.
- Venue
- Global Health Action
- Publisher
- Informa UK Limited
- Published
- 2018-01
- Volume
- 11
- Issue
- 1
- Pages
- 1447828
- ISSN
- 1654-9716 (ISSN-L)
- 1654-9880
- OpenAlex
- W2792261741
- Cited by
- 362
- References
- 34
- FWCI
- 17.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review. https://app.cochat.ai/papers/10.1080/16549716.2018.1447828
- The paper
- Cameron, D., Ubels, J., & Norström, F. (2018). On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review. Global Health Action. https://doi.org/10.1080/16549716.2018.1447828
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.